"A lot of the requests we receive from our clients are around doubling down on costs, becoming more efficient in conversion, produce higher grade polymers, and commercial excellence."
"Being able to service this region from Singapore plays out as a significant advantage for us. With the future growth potential of China in question, I believe Southeast Asia will be the beneficiary."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.